Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lubrizol develops and supplies specialty chemicals—including biotechnological extracts, peptides, polymers—for use in medical devices, pharmaceutical formulations/excipients, nutraceuticals, oral care products, and especially personal/beauty care. Clinical results cited include improvements in anti-aging parameters such as reduced pore size/luminosity from their Lectroglaze ingredient. The company does not develop prescription therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lubrico.